Our meta-analysis shows that the combined therapy of statins and metformin fails to improve insulin sensitivity and hyperinsulinaemia but decreases the serum levels of LDL-C, TC, TG and CRP; these findings are consistent with the therapeutic effect of statin therapy on women with PCOS. The gene discussed is CRP; the disease is polycystic ovary syndrome.